Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 22, 2019 18:31 ET | Source: Harvard Bioscience, Inc.

Harvard Bioscience Schedules Third Quarter 2019 Earnings Conference Call for November 5 at 4:30 PM ET

HOLLISTON, Mass., Oct. 22, 2019 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its quarterly results for third quarter ended September 30, 2019 after market close on...
October 21, 2019 08:45 ET | Source: Harvard Bioscience, Inc.

Harvard Bioscience Announces Executive Appointment

HOLLISTON, Mass., Oct. 21, 2019 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) announced today that Ken Olson has been named Vice President and General Manager, Pre-Clinical Systems...
September 09, 2019 08:00 ET | Source: Harvard Bioscience, Inc.

Harvard Bioscience Announces Strategic Action Plan and Financial Targets

HOLLISTON, Mass., Sept. 09, 2019 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announces its strategic action plan and financial targets for rest of year 2019 through 2021. Key...
September 04, 2019 16:45 ET | Source: Harvard Bioscience, Inc.

Harvard Bioscience to Present at Janney Healthcare Conference

HOLLISTON, Mass., Sept. 04, 2019 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) announced that Chairman, President and CEO, Jim Green, will be presenting at the Janney Montgomery Scott...
September 04, 2019 16:45 ET | Source: Harvard Bioscience, Inc.

Harvard Bioscience Elects Alan Edrick to Board of Directors

HOLLISTON, Mass., Sept. 04, 2019 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) announced today that its Board of Directors has elected Alan Edrick to Harvard Bioscience’s Board of...
July 25, 2019 16:00 ET | Source: Harvard Bioscience, Inc.

Harvard Bioscience Announces Quarter Ended June 30, 2019 Financial Results

- GAAP and adjusted non-GAAP revenue of $29.6 million- GAAP and adjusted non-GAAP earnings per share of $(0.01) and $0.04, respectively- 2019 guidance remains unchanged HOLLISTON, Mass., July 25,...
July 19, 2019 16:45 ET | Source: Harvard Bioscience, Inc.

Harvard Bioscience Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

HOLLISTON, Mass., July 19, 2019 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) announced today that in connection with Michael Rossi being named Chief Financial Officer on July 18,...
July 19, 2019 14:04 ET | Source: Harvard Bioscience, Inc.

Harvard Bioscience Schedules Second Quarter 2019 Earnings Conference Call for July 25 at 4:30 PM ET

HOLLISTON, Mass., July 19, 2019 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its quarterly results for the second quarter ended June 30, 2019 after market close on July...
July 18, 2019 17:44 ET | Source: Harvard Bioscience, Inc.

Harvard Bioscience Names Michael Rossi Chief Financial Officer

HOLLISTON, Mass., July 18, 2019 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) announced today that Michael Rossi has been named Chief Financial Officer, effective immediately. Rossi...
July 08, 2019 07:48 ET | Source: Harvard Bioscience, Inc.

James Green Named President and CEO of Harvard Bioscience

HOLLISTON, Mass., July 08, 2019 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) announced today that James Green has been named President and Chief Executive Officer of the Company by...